(3S,4S)-1-Benzyl-N,4-dimethyl-3-piperidinamine;Tofacitinib Impurity DT;Tropsch impurity;Tofatinib Impurity 23;Tofacitinib Impurity 34 Monomer;Nicotinamide Impurity 125
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>(3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine is a chiral pharmaceutical intermediate synthesized via asymmetric catalytic hydrogenation. <strong>Molecular Formula</strong>: C<sub>15</sub>H<sub>24</sub>N<sub>2</sub>. This stereoisomer ensures high enantiomeric purity for downstream drug manufacturing.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceutical Synthesis</strong>: Precursor for central nervous system active compounds.</li>
<li><strong>Medicinal Chemistry</strong>: Used in structure-activity relationship (SAR) studies.</li>
<li><strong>Custom Manufacturing</strong>: Bulk supply for API production facilities.</li>
</ul>
<h3>Precautions</h3>
<p>Store under inert atmosphere at 2-8°C. Use PPE to prevent inhalation or skin contact. Not approved for direct clinical use; strictly for industrial synthesis only.</p>